BioCentury | Mar 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: February 2018

...could help treat the craniofacial disorder Treacher Collins syndrome. Stanford University Distillery Therapeutics Neurology Addiction Regulator of G-protein signaling 20...
BioCentury | Feb 14, 2018
Distillery Therapeutics

Neurology

...Next steps could include identifying and testing RGS20 inhibitors in models of morphine addiction. TARGET/MARKER/PATHWAY: Regulator of G-protein signaling 20...
...Medicine at Mount Sinai, New York, N.Y. email: venetia.zachariou@mssm.edu Allison Johnson Icahn School of Medicine at Mount Sinai Regulator of G-protein signaling 20...
Items per page:
1 - 2 of 2